![A股调整或已进入尾声?投资主线有哪些?十大券商策略来了](https://i-invdn-com.investing.com/news/external-images-thumbnails/pic0666ec13410511ddd68f576953e3215a.png)
注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Tenaya Therapeutics Inc是一家临床前阶段的生物技术公司。该公司专注于发现、开发和提供治疗性疗法,以解决心脏病的潜在驱动因素。其正在推进一系列疾病修饰疗法,这些疗法是使用其产品平台和功能开发的,以针对患有罕见或其他流行形式的心脏病的患者的特定亚群。该公司正在推进来自基因治疗、细胞再生和精准医疗等三种不同产品平台的候选产品。该公司还在推进包括基因疗法和小分子在内的多样化管道。该公司的能力包括疾病模型、衣壳工程、启动子和监管要素、药物输送和制造。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Jin-Long Chen | 61 | 2016 | Independent Director |
David V. Goeddel | 72 | 2016 | Independent Chairman of the Board |
June H. Lee | 58 | 2021 | Independent Director |
Jeffrey T. Walsh | 58 | 2020 | Independent Director |
Douglas L. Mann | - | - | Member of Scientific Advisory Board |
Amy L. Burroughs | 53 | 2022 | Independent Director |
Alexander Marson | - | 2023 | Member of Scientific Advisory Board |
Elizabeth McNally | - | - | Member of Scientific Advisory Board |
R. Sanders Williams | 75 | 2016 | Independent Director |
Mark A. Kay | 65 | - | Member of Scientific Advisory Board |
Jonathan S. Weissman | - | - | Member of Scientific Advisory Board |
Karah Herdman Parschauer | 46 | 2021 | Independent Director |
Catherine Stehman-Breen | 61 | 2020 | Independent Director |
Christine Edry Seidman | - | 2023 | Member of Scientific Advisory Board |
Faraz Ali | 51 | 2018 | CEO & Director |
Eric N. Olson | - | - | Scientific Founder & Member of Scientific Advisory Board |
Deepak Srivastava | 57 | 2016 | Scientific Founder, Chairman of Scientific Advisory Board & Director |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核